Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
The constantly growing contribution of depressive disorders to the global disease statistics calls for a growth of treatment effectiveness and optimization. Antidepressants are the most frequently prescribed medicines for depressive disorders. However, development of a standardized pharmacotherapeut...
Guardado en:
Autores principales: | L. K. Khokhlov, N. E. Lukyanov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef2a9816e819456a8e250423b72feaf5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
por: Michelle Liu, et al.
Publicado: (2021) -
Pharmacogenetics
Publicado: (1991) -
Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review
por: Aboelbaha S, et al.
Publicado: (2021) -
Mind your state: Insights into antidepressant nonadherence
por: De Wet Wolmarans, et al.
Publicado: (2016) -
Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: Xandra García-González, et al.
Publicado: (2021)